Effects of Once and Twice Daily Dosing Regimen of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-040)
Clinical trial NCT01054300 · COMPLETED
Trial details
- NCT number
- NCT01054300
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-17
- Primary completion
- 2010-04-07
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.